Avalere Health
An Inovalon Company
Services

Federal & State Healthcare Policy

Predict Change

As the nation continues to struggle with improving outcomes, elevating quality, reducing costs, and driving value, federal and state policy activities remain core to making sound decisions for your business. Armed with policy experts and business strategists, Avalere guides organizations through the continued complexities of all aspects of healthcare public policy at both the federal and state levels. We help companies understand how changes to healthcare policy will affect coverage, access, payment, care delivery, and consumer choice. We partner with stakeholders from across the healthcare spectrum to help plan for insurance market reforms, Medicaid, Medicare Advantage, and Medicare Part D changes.

What's Your Challenge?

  • ​Policy Impact and Analysis
  • ​Policy Tracking and Monitoring
  • ​Comment Letters
  • ​Beneficiary Enrollment Trends

Complementary Products

Team

Meet a few of our experts ready to partner with you.

All Staff

Elizabeth Carpenter

Senior Vice President

Elizabeth
Carpenter

Elizabeth Carpenter, Senior Vice President, leads the Policy Practice at Avalere. Specifically, Elizabeth focuses on implementation of the Affordable Care Act, trends in commercial insurance, drug pricing policy, and the impact of politics on the policy landscape. 

Prior to joining Avalere, Elizabeth was a Senior Advisor in the Health Policy practice at McKenna Long & Aldridge LLP and the Associate Policy Director for the Health Policy Program at the New America Foundation. Previously, she served on both the legislative and campaign staffs of Senator Lincoln Chafee (RI).

Elizabeth has a BA in Political Science from Brown University.

Gillian Woollett

Senior Vice President

Gillian
Woollett

Gillian Woollett, Senior Vice President, leads our FDA Practice. She provides the "prequel" of scientific and regulatory strategic policy expertise that supports medicinal products gaining approval at the FDA in a manner that allows them to be successful in the public and private reimbursement world. She is building a bridge for Avalere clients from the FDA space into the traditionally separate Centers for Medicare & Medicaid Services and healthcare policy/business world.

Prior to joining Avalere, Gillian was Chief Scientist at Engel & Novitt, LLP, and was Vice President, Science and Regulatory Affairs at the Biotechnology Industry Organization (BIO). She joined BIO after being Associate Vice President at the Pharmaceutical Research and Manufacturers of America. She has been an appointee on federal advisory committees to the CDC and the Department of Commerce. Trained as a molecular biologist/immunologist, Gillian publishes in peer-reviewed literature on biotechnology topics, and is a frequent speaker on emerging biosciences and their ability to support better and more focused therapies.

Gillian has a BA, MA in the Natural Sciences Tripos (Biochemistry) from the University of Cambridge, and a DPhil in Immunology from the University of Oxford.

Chris Sloan

Senior Manager

Chris
Sloan

Chris Sloan, Senior Manager, provides strategic and analytic support to pharmaceutical, health plan, and provider clients on federal and state policy issues. He has particular expertise in the policy areas around insurance exchanges, drug pricing, and benefit design. Additionally, he specializes in specific therapeutic areas including multiple sclerosis, hepatitis C, and HIV/AIDS. 

Prior to joining Avalere, Chris worked as a media intern at Mary Washington Healthcare, a healthcare provider network.

Chris has a BBA in Economics and Marketing from The College of William and Mary.

Kelly Brantley

Vice President

Kelly
Brantley

Kelly Brantley, Vice President, provides strategic analysis and advice to help clients predict and navigate the changing healthcare landscape, particularly as it relates to health insurance exchanges and the Medicare program. Her areas of focus include benefit design, prescription drug formularies, essential health benefits, risk adjustment, actuarial value, and overall insurance market regulation.

Prior to joining Avalere, Kelly worked at the Health Assistance Partnership/Families USA, where she analyzed Medicare Part D policy and as a consultant for the ECRI Institute.

Kelly has an MPH in Health Promotion and a Graduate Certificate in Health Policy from the George Washington University School of Public Health and Health Services and a BS in Biology from the University of North Carolina at Chapel Hill.

« Back to Mobile Site